BHST · BioHarvest Sciences filed a Form 6-K announcing that it will report Q3…

BioHarvest Sciences filed a Form 6-K announcing that it will report Q3 2026 financial results on November 12, 2026, before market open. The filing contains no financial data, guidance, or material operational updates, it is purely a results-date notice.

• Q3 2026 results will be released before market open on November 12, 2026
• Conference call and webcast scheduled for 8:00 AM Eastern Time on November 12, 2026
• CEO Zaki Rakib will discuss strategic transformation to a CDMO-focused company
• No financial results, guidance, or material business updates are included in this filing